4-[4-(4-Fluoro­phen­yl)-2-methyl-5-oxo-2,5-dihydro­isoxazol-3-yl]-1-methyl­pyridinium iodide–4-[3-(4-fluoro­phen­yl)-2-methyl-5-oxo-2,5-dihydro­isoxazol-4-yl]-1-methyl­pyridinium iodide (0.6/0.4)

Margutti, S.; Schollmeyer, D.; Laufer, S.

doi:10.1107/S1600536807055985

Acta Crystallographica Section E
Acta Crystallographica
Section E CRYSTALLOGRAPHIC COMMUNICATIONS

IUCr IT WDC

home archive editors for authors for readers submit open access

view article

Figure 1 Schematic drawing of important interactions between the prototypical pyridin-4-yl imidazole inhibitor SB 203580 and the ATP binding site of p38.

CRYSTALLOGRAPHIC
COMMUNICATIONS

ISSN: 2056-9890

Volume 64| Part 1| January 2008| Pages o298-o299

https://doi.org/10.1107/S1600536807055985

Open

access

Follow Acta Cryst. E

Search IUCr Journals		doi		Advanced search
Author		volume	page